Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
22.23
+0.81 (3.78%)
Apr 2, 2026, 2:47 PM EDT - Market open
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $2.18 billion as of April 2, 2026. Its market cap has decreased by -39.32% in one year.
Market Cap
2.18B
Enterprise Value
2.69B
1-Year Change
-39.32%
Ranking
Category
Stock Price
$22.23
Market Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $2.18B, an increase of 83.46%. That is a compound annual growth rate of 5.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 2.07B | -6.72% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADMA Biologics | 2.15B |
| Adaptive Biotechnologies | 2.14B |
| Zai Lab | 2.12B |
| Celldex Therapeutics | 2.11B |
| Nektar Therapeutics | 2.06B |
| Tyra Biosciences | 2.06B |
| Syndax Pharmaceuticals | 2.06B |
| Viridian Therapeutics | 2.00B |